Cargando…
Novel analytical methods to interpret large sequencing data from small sample sizes
BACKGROUND: Targeted therapies have greatly improved cancer patient prognosis. For instance, chronic myeloid leukemia is now well treated with imatinib, a tyrosine kinase inhibitor. Around 80% of the patients reach complete remission. However, despite its great efficiency, some patients are resistan...
Autores principales: | Lichou, Florence, Orazio, Sébastien, Dulucq, Stéphanie, Etienne, Gabriel, Longy, Michel, Hubert, Christophe, Groppi, Alexis, Monnereau, Alain, Mahon, François-Xavier, Turcq, Béatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717342/ https://www.ncbi.nlm.nih.gov/pubmed/31470908 http://dx.doi.org/10.1186/s40246-019-0235-1 |
Ejemplares similares
-
A genome‐scale CRISPR knock‐out screen in chronic myeloid leukemia identifies novel drug resistance mechanisms along with intrinsic apoptosis and MAPK signaling
por: Lewis, Matthieu, et al.
Publicado: (2020) -
Second‐ or third‐generation tyrosine kinase inhibitors in first‐line treatment of chronic myeloid leukemia in general population: Is there a real benefit?
por: Canet, Jim, et al.
Publicado: (2021) -
Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells: A Cellular Reservoir Participating in Dasatinib Efficiency
por: Airiau, Kelly, et al.
Publicado: (2018) -
Ovarian cyst removal influences ovarian reserve dependent on histology, size and type of operation
por: Henes, Melanie, et al.
Publicado: (2018) -
The relationship between breast size and aspects of health and psychological wellbeing in mature-aged women
por: Spencer, Linda, et al.
Publicado: (2020)